Immunotherapy, Adoptive

"Immunotherapy, Adoptive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)

Descriptor ID	D016219
MeSH Number(s)	E02.095.465.425.400.330.050.400 E05.478.550.520.050.400
Concept/Terms	Immunotherapy, Adoptive Immunotherapy, Adoptive Immunotherapy, Adoptive Cellular Adoptive Immunotherapy Adoptive Immunotherapies Immunotherapies, Adoptive Cellular Immunotherapy, Adoptive Adoptive Cellular Immunotherapies Cellular Immunotherapies, Adoptive Immunotherapies, Adoptive Cellular Adoptive Cellular Immunotherapy

Below are MeSH descriptors whose meaning is more general than "Immunotherapy, Adoptive".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Biological Therapy [E02.095]
Immunomodulation [E02.095.465]
Immunotherapy [E02.095.465.425]
Immunization [E02.095.465.425.400]
Immunization, Passive [E02.095.465.425.400.330]
Adoptive Transfer [E02.095.465.425.400.330.050]
Immunotherapy, Adoptive [E02.095.465.425.400.330.050.400]
Investigative Techniques [E05]
Immunologic Techniques [E05.478]
Immunization [E05.478.550]
Immunization, Passive [E05.478.550.520]
Adoptive Transfer [E05.478.550.520.050]
Immunotherapy, Adoptive [E05.478.550.520.050.400]

Below are MeSH descriptors whose meaning is related to "Immunotherapy, Adoptive".

Below are MeSH descriptors whose meaning is more specific than "Immunotherapy, Adoptive".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunotherapy, Adoptive" by people in this website by year, and whether "Immunotherapy, Adoptive" was a major or minor topic of these publications.

Bar chart showing 47 publications over 16 distinct years, with a maximum of 8 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2000	1	1	2
2010	1	0	1
2011	1	0	1
2012	0	2	2
2013	1	2	3
2014	1	0	1
2015	0	1	1
2017	2	0	2
2018	3	0	3
2019	2	0	2
2020	1	1	2
2021	4	2	6
2022	1	4	5
2023	1	6	7
2024	5	3	8

Below are the most recent publications written about "Immunotherapy, Adoptive" by people in Profiles.

Diorio C, Hernandez-Miyares L, Espinoza DA, Banwell BL, Bar-Or A, DiNofia AM, Barz Leahy A, Martinez Z, Myers RM, Hopkins SE, Rheingold SR, Teachey DT, Viaene AN, Wray LM, Maude SL, Grupp SA, McGuire JL. Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood. 2024 09 26; 144(13):1387-1398.

View in: PubMed
Baybutt TR, Entezari AA, Caspi A, Staudt RE, Carlson RD, Waldman SA, Snook AE. CD8a Structural Domains Enhance GUCY2C CAR-T Cell Efficacy. Cancer Biol Ther. 2024 12 31; 25(1):2398801.

View in: PubMed
Pascual-Pasto G, McIntyre B, Giudice AM, Alikarami F, Morrissey A, Matlaga S, Hofmann TJ, Burgue?o V, Harvey K, Martinez D, Shah AC, Foster JB, Pogoriler J, Eagle RC, Carcaboso AM, Shields CL, Leahey AM, Bosse KR. Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells. Clin Cancer Res. 2024 Aug 15; 30(16):3578-3591.

View in: PubMed
Grosso D, Wagner JL, O'Connor A, Keck K, Huang Y, Wang ZX, Mehler H, Leiby B, Flomenberg P, Gergis U, Nikbakht N, Morris M, Karp J, Peedin A, Flomenberg N. Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19. Blood Adv. 2024 08 13; 8(15):4113-4124.

View in: PubMed
Patel RP, Ghilardi G, Zhang Y, Chiang YH, Xie W, Guruprasad P, Kim KH, Chun I, Angelos MG, Pajarillo R, Hong SJ, Lee YG, Shestova O, Shaw C, Cohen I, Gupta A, Vu T, Qian D, Yang S, Nimmagadda A, Snook AE, Siciliano N, Rotolo A, Inamdar A, Harris J, Ugwuanyi O, Wang M, Carturan A, Paruzzo L, Chen L, Ballard HJ, Blanchard T, Xu C, Abdel-Mohsen M, Gabunia K, Wysocka M, Linette GP, Carreno B, Barrett DM, Teachey DT, Posey AD, Powell DJ, Sauter CT, Pileri S, Pillai V, Scholler J, Rook AH, Schuster SJ, Barta SK, Porazzi P, Ruella M. CD5 deletion enhances the antitumor activity of adoptive T cell therapies. Sci Immunol. 2024 07 19; 9(97):eadn6509.

View in: PubMed
Karmali R, Machhi R, Epperla N, Shouse G, Romancik J, Moyo TK, Kenkre V, Ollila TA, Fitzgerald L, Hess B, David K, Roy I, Zurko J, Chowdhury SM, Annunzio K, Ferdman R, Bhansali RS, Harris EI, Liu J, Nizamuddin I, Ma S, Moreira J, Winter J, Pro B, Stephens DM, Danilov A, Shah NN, Cohen JB, Barta SK, Torka P, Gordon LI. Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood Adv. 2024 05 28; 8(10):2592-2599.

View in: PubMed
Gardner RA, White C, Elsallab M, Farnia S, Fraint E, Grilley B, Bateman-House A, Grupp SA, Kenderian S, Locke FL, Nikiforow S, Oluwole OO, Rouce RH, Spiegel J, Shah NN, Sharma A, Komanduri K, Gill S. ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies. Transplant Cell Ther. 2024 08; 30(8):776-787.

View in: PubMed
King Z, Fraint E. Chimeric Antigen Receptor T-Cell Treatment in Children. Pediatr Rev. 2024 May 01; 45(5):301-302.

View in: PubMed
Hasanali ZS, Razzo B, Susanibar-Adaniya SP, Garfall AL, Stadtmauer EA, Cohen AD. Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma. Hematol Oncol Clin North Am. 2024 04; 38(2):383-406.

View in: PubMed
Razzo B, Garfall AL, Cohen AD. Options at the time of relapse after anti-BCMA therapy. Hematology Am Soc Hematol Educ Program. 2023 12 08; 2023(1):450-458.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement